STC1 Antibodies

Santa Cruz Biotechnology delivers a wide array of STC1 monoclonal antibodies for investigating STC1 protein function. STC1 Antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). STC1, or Stanniocalcin 1, is a glycoprotein that plays a critical role in calcium and phosphate homeostasis, as well as in cellular responses to stress. Research has shown STC1's involvement in various physiological processes, including bone metabolism and the regulation of cell survival. Understanding STC1 function is essential for elucidating its role in diseases such as cancer and metabolic disorders. Current research indicates that STC1 may serve as a potential therapeutic target in various pathological conditions. Ongoing studies continue to reveal new insights about STC1's biological significance and regulatory mechanisms. Recent findings suggest that STC1 could be a valuable biomarker for disease progression and treatment response. Santa Cruz Biotechnology monoclonal antibodies for STC1 enable researchers worldwide to advance scientific understanding of this important protein's role in health and disease.